drugset / Trial / NCT01213121

Neurophysiologic Changes in Patients With Bipolar Depression

NCT01213121

Phase 4 Unknown 60 enrolled Seoul National University Bundang Hospital
Non-randomizedFactorialOpen-labelBasic science

Summary

* To examine differences in neurophysiologic parameters between unmedicated patients with bipolar depression and healthy controls * To examine within-subject changes in neurophysiologic parameters in patients with bipolar depression treated with quetiapine

Timeline

Start
2010-09
Primary completion
2014-10
Completion
2015-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Quetiapine Small molecule 25 mg Oral
Subject Quetiapine Small molecule 600 mg Oral

Indications